Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology

Citation
G. Walzl et al., Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology, J EXP MED, 192(9), 2000, pp. 1317-1326
Citations number
50
Categorie Soggetti
Medical Research General Topics
Journal title
JOURNAL OF EXPERIMENTAL MEDICINE
ISSN journal
00221007 → ACNP
Volume
192
Issue
9
Year of publication
2000
Pages
1317 - 1326
Database
ISI
SICI code
0022-1007(20001106)192:9<1317:IVLIPF>2.0.ZU;2-Z
Abstract
The effect of infection history is ignored in most animal models of infecti ous disease. The attachment protein of respiratory syncytial virus (RSV) in duces T helper cell type 2-driven pulmonary eosinophilia in mice similar to that seen in the failed infant vaccinations in the 1960s. We show that pre vious influenza virus infection of mice: (a) protects against weight loss, illness, and lung eosinophilia; (b) attenuates recruitment of inflammatory cells; and (c) reduces cytokine secretion caused by RSV attachment protein without affecting RSV clearance. This protective effect can be transferred via influenza-immune splenocytes to naive mice and is long lived. Previous immunity to lung infection clearly plays an important and underestimated ro le in subsequent vaccination and infection. The data have important implica tions for the timing of vaccinations in certain patient groups, and may con tribute to variability in disease susceptibility observed in humans.